PUBLICATIONS · 28712941
Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Haematol
- Publication date
- 2017 Aug
- First author
- Jurczak W
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Haematol. 2017 Aug;4(8):e342-e343. doi: 10.1016/S2352-3026(17)30124-2.
- note
- Source null
- related pmid
- 28712939
- relationship
- Comment in
- citation
- Lancet Haematol. 2017 Aug;4(8):e341. doi: 10.1016/S2352-3026(17)30127-8.
- note
- Source null
- related pmid
- 28754191
- relationship
- Comment in
Authors and identifiers
- name
- Jurczak W
- type
- Author
- name
- Moreira I
- type
- Author
- name
- Kanakasetty GB
- type
- Author
- name
- Munhoz E
- type
- Author
- name
- Echeveste MA
- type
- Author
- name
- Giri P
- type
- Author
- name
- Castro N
- type
- Author
- name
- Pereira J
- type
- Author
- name
- Akria L
- type
- Author
- name
- Alexeev S
- type
- Author
- name
- Osmanov E
- type
- Author
- name
- Zhu P
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Jurczak W
- type
- Author
- name
- Moreira I
- type
- Author
- name
- Kanakasetty GB
- type
- Author
- name
- Munhoz E
- type
- Author
- name
- Echeveste MA
- type
- Author
- name
- Giri P
- type
- Author
- name
- Castro N
- type
- Author
- name
- Pereira J
- type
- Author
- name
- Akria L
- type
- Author
- name
- Alexeev S
- type
- Author
- name
- Osmanov E
- type
- Author
- name
- Zhu P
- type
- Author
- bibliography ids
- nci-bib-8bca51af58e8fb01ce6efa3e
- book metadata
- content sha256
- aa1310763586c8d598fd07359ab13938335eb97ee005ca325ede4d7404a7be0d
- document type
- citation
- dois
- 10.1016/S2352-3026(17)30106-0
- electronic publication date
- display
- 2017 Jul 14
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28712941
- immutable id
- pubmed:28712941@aa1310763586c8d598fd07359ab13938335eb97ee005ca325ede4d7404a7be0d
- journal
- abbreviation
- Lancet Haematol
- issn electronic
- 2352-3026
- issn print
- Source null
- issue
- 8
- name
- The Lancet. Haematology
- nlm unique id
- 101643584
- pages
- e350-e361
- volume
- 4
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Haematol. 2017 Aug;4(8):e342-e343. doi: 10.1016/S2352-3026(17)30124-2.
- note
- Source null
- related pmid
- 28712939
- relationship
- Comment in
- citation
- Lancet Haematol. 2017 Aug;4(8):e341. doi: 10.1016/S2352-3026(17)30127-8.
- note
- Source null
- related pmid
- 28754191
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 28712941
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- ee3b439e93aaa4384b3aea7f0a5441ac2b1e68c7d87fca43fc1d8a616c3c4849
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Aug
- precision
- month
- year
- 2017
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle